ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

How will Trump-EU trade deal affect global markets? What led to Tesla’s $16.5B AI chip deal with Samsung? Why did the FDA lift hold on Sarepta’s therapy? How are US-China trade talks impacting tariffs? What caused the selloff in Swiss chemical stocks? How will Procter & Gamble’s new CEO reshape the company? Why are AI investments boosting certain tech stocks?

ATAI Life Sciences, Revvity And Other Big Stocks Moving Lower In Monday's Pre-Market Session

benzinga.com/trading-ideas/movers/25/07/46656937/atai-life-sciences-revvity-and-other-big-stocks-moving-lower-in-mondays-pre-market-session

U.S. stock futures were higher this morning, with the Nasdaq futures gaining around 0.3% on Monday.
Shares of ATAI Life Sciences NV (NASDAQ:ATAI) fell sharply in pre-market trading after the company announced the Phase 2b trial of Inidascamine in patients with cognitive impairment…

This story appeared on benzinga.com, 2025-07-28 12:13:34.